MIRA INFORM REPORT

 

 

Report Date :

20.06.2014

 

IDENTIFICATION DETAILS

 

Name :

DROGUERIA LIBERTAD S.A.

 

 

Registered Office :

Estados Unidos No.1846 (1227),  Buenos Aires City

 

 

Country :

Argentina

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

04.03.1986

 

 

Legal Form :

Public Limited Company

 

 

Line of Business :

·         engaged in the commercialization of Chemical Products in General, Medicinal Specialities and Veterinary Products

·         importer of Antibiotics, Peniciline and its derivatives as well as amoxiline

 

 

No of Employees :

30

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

Argentina

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


argentina ECONOMIC OVERVIEW

 

Argentina benefits from rich natural resources, a highly literate population, an export-oriented agricultural sector, and a diversified industrial base. Although one of the world's wealthiest countries 100 years ago, Argentina suffered during most of the 20th century from recurring economic crises, persistent fiscal and current account deficits, high inflation, mounting external debt, and capital flight. A severe depression, growing public and external indebtedness, and an unprecedented bank run culminated in 2001 in the most serious economic, social, and political crisis in the country's turbulent history. Interim President Adolfo RODRIGUEZ SAA declared a default - at the time the largest ever - on the government's foreign debt in December of that year, and abruptly resigned only a few days after taking office. His successor, Eduardo DUHALDE, announced an end to the peso's decade-long 1-to-1 peg to the US dollar in early 2002. The economy bottomed out that year, with real GDP 18% smaller than in 1998 and almost 60% of Argentines under the poverty line. Real GDP rebounded to grow by an average 8.5% annually over the subsequent six years, taking advantage of previously idled industrial capacity and labor, an audacious debt restructuring and reduced debt burden, excellent international financial conditions, and expansionary monetary and fiscal policies. Inflation also increased, however, during the administration of President Nestor KIRCHNER, which responded with price restraints on businesses, as well as export taxes and restraints, and beginning in 2007, with understating inflation data. Cristina FERNANDEZ DE KIRCHNER succeeded her husband as President in late 2007, and the rapid economic growth of previous years began to slow sharply the following year as government policies held back exports and the world economy fell into recession. The economy in 2010 rebounded strongly from the 2009 recession, but has slowed since late 2011 even as the government continued to rely on expansionary fiscal and monetary policies, which have kept inflation in the double digits. The government expanded state intervention in the economy throughout 2012. In May 2012 the Congress approved the nationalization of the oil company YPF from Spain's Repsol. The government expanded formal and informal measures to restrict imports during the year, including a requirement for pre-registration and pre-approval of all imports. In July 2012 the government also further tightened currency controls in an effort to bolster foreign reserves and stem capital flight. During 2013, the government continued with a mix expansionary fiscal and monetary policies and foreign exchange and imports controls to limit the drain in Central Bank foreign reserves, which nevertheless dropped US $12 billion during the year. GDP grew 3% and inflation remained steady at 25%, according to private estimates. In October 2013, the government settled long-standing international arbitral disputes (including with three US firms) dating back to before and following the 2002 Argentine financial crisis. In early 2014, the government embraced a series of more orthodox economic policies. It devalued the peso 20%, substantially tightened monetary and fiscal policies, and took measures to mend ties with the international financial community, including: engaging with the IMF to improve its economic data reporting, reaching a compensation agreement with Repsol for the expropriation of YPF, and presenting a proposal to pay its arrears to the Paris Club.

 

 

Source : CIA

 

 

 


Registered Name   

 

DROGUERIA LIBERTAD S.A.

CUIT: 30-60937302-0

 

 

Summary      

 

INCORPORATED IN 1986. BEGINNER OF ACTIVITIES. BALANCE SHEET AS OF 31/12/2012: LAST KNOW. FULFILLMENT: WITHOUT OBJECTIONS. FIT FOR CREDITS IN ACCORDANCE WITH ITS KNOWN ECONOMIC-FINANCIAL RESOURCES. FOR HIGHER AMOUNTS, TAKE APPROPRIATE GUARANTEES.  

 

 

Operations       

 

DRUGSTORE    
CHEMICAL AND PHARMACEUTICAL PRODUCTS    
COMMERCIALIZATION

 

 

Legal Structure   

 

Business type:              Public Limited Company
Incorporated:                04/03/1986
Registered:                   19/05/1986 - Nº 2886, Book 102, Volume A
Duration:                      99 years
End of fiscal year:        December 31st

Afip Nro 5 de Salta 1449 Ciudad de Buenos Aires.

 

 

Contact       

 

Legal, Administrative and Sales address: Estados Unidos No.1846 (1227),  Buenos Aires City, Argentine Republic.  
   
Phone: (54-11) 4306-0800 (lineas rotativas)
Fax.: (54-11) 4306-1010

CODIGO POSTAL 1227

E-mail:              info@droguerialibertad.com.ar
Website:           www.droguerialibertad.com.ar

 

Partners     

 

President:                     VARAS PABLO AUGUSTO
Vice-president:              LOPEZ MORILLO MARIA VIRGINIA

Director:                                   VARAS MARCOS JAVIER        
Director:                                   VARAS MARIA BELEN

Alternate Director:         VARAS MARIA VALERIA

The first two mentioned ones, as Managers, are in charge of the management and administration of the company, with the use of the social signature.

 

 

Corporate Stock       

 

COMMON SHARES:
--------------
SUBSCRIBED AND PAID-IN CAPITAL: $ 665.000,60

 

 

Personal Information   

 

VARAS PABLO AUGUSTO:
Argentinian, married, born on 21/12/1953, DNI. 10.983.619 (CUIT. 20-10983619-3), with address in Esmeralda 1319, 2º "64", Buenos Aires City.

He registers backgrounds as President of MAVEBEI S.A. which since 1999 has been performing real estate operations.

LOPEZ MORILLO MARIA VIRGINIA:
Argentinian, married, born on 20/04/1955, Merchant, DNI. 11.768.997 (CUIT. 27-11768997-8) with address in Pichincha 875, Buenos Aires City.

She registers backgrounds as Vice-president of MAVEBEI S.A. and as partner of LABORATORIOS INDEX S.R.L.

VARAS MARCO JAVIER:
Argentinian, single, DNI. 26.023.808.

 

 

History   

 

It was incorporated at early 1986 with the objective of performing its current activities, working in the previously exposed addresses.  

 


There is no register about its participation in other economic group, highlighting that some of its directors participate in other companies, which have already been mentioned.

 

Before had the operative address: Piedras 1516, lº "A", Buenos Aires City.

 

 

Economic-Financial Position   

 

BALANCE SHEET AS OF 31/12/2012 (last know).

ASSETS:                          2011         2012
------                           ----         ----

Cash, Banks, Credit, etc..   20.980.888    22.997.025
Inventories                  13.906.161    11.052.971
                            ----------   ----------
Total current                34.887.049    34.049.996
Total non-current               493.835       667.694
                            ----------   ----------
TOTAL ASSETS                 35.380.884    34.717.690
                            ==========   ==========

LIABILITIES:
------------

Debts                         7.386.790     3.156.696
Salaries and social security    244.318        96.718

                            ----------   ----------
Total current                 7.631.108     3.253.414

                            ----------   ----------
Total liabilities             7.631.108     3.253.414
                            ----------   ----------
Net worth                    27.749.776    31.464.276
                            ----------   ----------
LIAB. AND NET WORTH          35.380.884    34.717.690
                            ==========   ==========

INCOME STATEMENT:
-----------------

Net sales                    43.880.203    61.453.943
Cost of sales              - 29.493.548   -42.541.121
                            ----------   ----------
GAIN                         14.386.655    18.912.822
                            ----------   ----------
Marketing expenses          - 2.510.690   - 3.581.628
Administrative expenses     - 5.805.306   - 7.124.706
                            ----------   ----------
Total expenditure             6.070.659     8.206.488
                            ----------   ----------
Operative result              3.387.356     7.043.915
                            ----------   ----------
OTHERS EXPENSES               6.335.789     7.842.791

 

 

Assets     

 

REAL ESTATE:
--------------------
Estados Unidos No.1846 (1227),  Buenos Aires City, Argentine Republic.

VEHICLES:  
---------  
3 vans of different brands and models, not having detailed information about them.  

 

 

Evolution and Results       

 

The company is mainly engaged in the commercialization of chemical products in general, medicinal specialities and veterinary products, having its headquarters in the previously exposed addresses.  
 
It has an appropriate infrastructure and organization, where its directors participate together with 30 employees.  
 
Imports from China, Indian, Mexico, and others countries.

The main imported products were antibiotics, peniciline and its derivatives as well as amoxiline

MAIN SUPPLIERS:
---------------
FERROMET S.A.
DISTRIBUIDORA MATERIA S.A.
L.U.P. (CHINA)
FERCIMSA (SPAIN-MEXICO)

* 30 EMPLOYEES

 

 

Branches     

 

Warehouse: Pichincha 875, 1º "A", Buenos Aires City, Argentine Republic.

 

 


Payment Record and Credit Risk      

 

BANKS:
-------------
* BANCO DE LA NACION ARGENTINA         Branch: Pza.de Mayo - Current Account N° 32800/67
* ICBC BANK                        Principal Office    - Current Account Nº 041369700
* PROVINCIA DE BUENOS AIRES

CREDIT RISK APRIL 2014.
----------------------

BANCO DE LA NACION ARGENTINA..........$ 1.654.300
ICBC..................................$ 1.401.400
BANCO PROV. BUENOS AIRES..............$    98.800
MERCEDES BENZ.........................$    45.300
BANCO CREDICOOP.......................$     2.000

SITUATION 1: NORMAL

INSURANCE:
----------
CONSOLIDAR S.A.

 

 

Concept       

 

Up to now the company has complied in due time the commitments taken and has a good concept.

* FULFILLMENT: WITHOUT OBJECTIONS AT PRESENT.

 

 

Final Opinion    

 

We consider feasible the credit treatment with this company by amounts in accordance with its known economic-financial resources and additional guarantees.


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.00

UK Pound

1

Rs.102.05

Euro

1

Rs.81.71

 

 

INFORMATION DETAILS

 

Analysis Done by :

SUB

 

 

Report Prepared by :

MNL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

--

NB

                                       New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.